Modelling the dynamics of Anti-HBV Infection Therapy with Chinese Herbs

被引:0
|
作者
Ye, Yongan [1 ]
Min, Lequan [2 ]
机构
[1] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100700, Peoples R China
[2] Univ Sci & Technol Beijing, Appl Sci Sch, Beijing 100083, Peoples R China
关键词
hepatitis B; Chinese Herbs; anti-HBV infection therapy model; CHRONIC HEPATITIS-B; VIRUS-INFECTION; COMBINATION; LAMIVUDINE;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Effective treatment of chronic Hepatitis B virus (HBV) patients aims to prevent progression of chronic hepatitis B to cirrhosis, hepatocellular carcinoma, and eventually death. The use of mathematical modelling to explain the anti-HBV infection therapy has made a significant contribution for understanding the dynamics of host cells, viruses, the immune system. Chinese herbs are playing important roles for anti-HBV infection treatment. Recently a new type of Chinese herbs (NTCH) has been proved to be effective for anti-HBV infection therapy. Based on a patient's anti-hepatitis B virus (HBV) infection therapy clinical data with the NTCH and our previous modified basic virus infection model [1], a new differential equation model with an immune variable is set up. The numerical simulations of the model show that the evolution of the HBV DNA of the model is agreement with in the patient's clinic plasma HBV DNA levels. The model predicts that it needs to prolong the treatment time to 4.3 years to eliminate NTCH the HBV virus in the patient's infected hepatocytes. Otherwise earlier cessation of the therapy will make the patient's HBV DNA levels return rapidly.
引用
收藏
页码:83 / +
页数:2
相关论文
共 50 条
  • [1] A Mathematical Model of the Dynamics for Anti-HBV Infection Therapy with Chinese Herbs plus Adefovir Dipivoxi
    Min, Lequan
    Ye, Yongan
    2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, 2009, : 3000 - +
  • [2] Dynamics analysis of an amended HBV infection model with a simulation for anti-HBV infection therapy
    Chen Xiao
    Sun Kaiyun
    Qu Jianlong
    Chen Xiangyong
    Yang Chengdong
    Zhang Ancai
    2014 33RD CHINESE CONTROL CONFERENCE (CCC), 2014, : 2829 - 2834
  • [3] Modeling and Simulation for Dynamics of Tenofovir Disoproxil Fumarate Anti-HBV Infection Therapy
    Chen, Xiao
    Qiu, Jianlong
    Qin, Weiqi
    Li, Tongxing
    Yang, Chengdong
    2017 CHINESE AUTOMATION CONGRESS (CAC), 2017, : 7307 - 7310
  • [4] HBV infection modeling and numerical simulation for anti-HBV infection personalized combination therapy
    Chen, X.
    Min, L. Q.
    Ye, Y. A.
    Zhang, Q.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S28 - S28
  • [5] A controlled study of anti-HBV vaccine therapy in chronic hepatitis B infection
    Pol, S
    Driss, F
    Couillin, I
    Denis, J
    Tiollais, P
    Michel, ML
    Bréchot, C
    HEPATOLOGY, 1998, 28 (04) : 488A - 488A
  • [6] A mathematical model for anti-HBV infection combination therapy with lamivudine and adevovir divipoxil
    Xie, Qizhi
    Zhang, Shuangde
    Huang, Dongwei
    2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, 2009, : 2996 - +
  • [7] Chinese herbal medicine long-term anti-HBV infection personalized treatments
    Ye, Y. A.
    Min, L. Q.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S80 - S80
  • [8] A mathematical model of dynamics for anti-HBV infection treatment with peginterferon alpha-2a
    Min, L.
    Li, W.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S27 - S27
  • [9] Modeling adefovir dipivoxil anti-HBV infection treatment
    Min, L. Q.
    Zhang, P. F.
    Li, Y. J.
    Meng, L.
    Zhang, J.
    Zhou, L.
    Zhang, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S65 - S65
  • [10] IMPACT OF HBV VARIANT FITNESS ON THEIR SELECTION DURING ANTI-HBV THERAPY
    Villet, Stephanie
    Billioud, Gaetan
    Pichoud, Christian
    Lucifora, Julie
    Hantz, Olivier
    Sureau, Camille C.
    Deny, Paul
    Zoulim, Fabien
    HEPATOLOGY, 2008, 48 (04) : 677A - 677A